Last 4,358 GBp
Change Today +35.00 / 0.81%
Volume 3.2M
AZN On Other Exchanges
Symbol
Exchange
New York
Xetra
London
Stockholm
OTC US
Mexico
Berlin
As of 11:35 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pascal Soriot

Chief Executive Officer, Executive Director and Member of Disclosure Committee, AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 8 different industries.

See Board Relationships
553,344,000 GBP
As of Fiscal Year 2013

Background*

Mr. Pascal Soriot has been the Chief Executive Officer of AstraZeneca PLC since October 1, 2012. Mr. Soriot served as the Chief Operating Officer of Roche Pharma AG from 2010 to September 1, 2012. He served as the Chief Operating Officer of Roche Pharmaceuticals at Roche Diabetes Care AG. He served as the Chief Operating Officer of Pharmaceuticals at Roche Holding AG since January 1, 2010 and served as its Head of Pharma Medicines. He served as the Chief Executive Officer ...

Read Full Background

Corporate Headquarters*

2 Kingdom Street
London, Greater London W2 6BD

United Kingdom

Phone: 44 20 7604 8000
Fax: 44 20 7604 8151

Board Members Memberships*

Former Director
Former Director
2012-Present
Chief Executive Officer, Executive Director and Member of Disclosure Committee

Education*

Doctorate
Ecole Nationale Vtrinaire at Maisons-Alfort
MBA
Groupe HEC

Other Affiliations*

Annual Compensation*

Salary1,100,000 GBP
Bonus1,870,000 GBP
Total Annual Compensation2,970,000 GBP

Stock Options*

All Other Compensation374,000 GBP

Total Compensation*

Total Annual Cash Compensation3,344,000 GBP
Total Short Term Compensation2,970,000 GBP
Other Long Term Compensation374,000 GBP
Total Calculated Compensation3,344,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:LN 4,357.50 GBp +35.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.